
Chembio Diagnostics CEMI
Annual report 2022
added 03-29-2023
Chembio Diagnostics DPO Ratio 2011-2025 | CEMI
Annual DPO Ratio Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.5 | 71.3 | 87.6 | 51.2 | 61.7 | 42.2 | 55.7 | 33.4 | 42.9 | 38.4 | 41.5 | 45.9 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 87.6 | 33.4 | 52 |
Quarterly DPO Ratio Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 14.5 | - | 40.1 | - | 68.6 | 135 | 152 | - | 70 | 92.2 | 92.5 | - | 43.1 | 41 | 61.6 | - | 14.6 | 53.5 | 52.8 | - | 33.6 | 61.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 152 | 14.5 | 64.2 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
125 | $ 16.9 | 7.3 % | $ 183 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
104 | $ 1.57 | -3.08 % | $ 2 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 38.44 | -0.5 % | $ 1.07 B | ||
|
DarioHealth Corp.
DRIO
|
43.9 | $ 12.0 | 0.93 % | $ 340 M | ||
|
DexCom
DXCM
|
70.4 | $ 66.39 | -0.85 % | $ 25.6 B | ||
|
Danaher Corporation
DHR
|
66.4 | $ 226.5 | - | $ 166 B | ||
|
Exact Sciences Corporation
EXAS
|
139 | $ 101.57 | 0.07 % | $ 18.8 B | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 26.81 | -1.22 % | $ 811 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 19.74 | -3.99 % | $ 1.06 B | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
1.29 K | $ 3.53 | -1.4 % | $ 113 K | ||
|
Co-Diagnostics
CODX
|
106 | $ 0.31 | -9.4 % | $ 9.1 M | ||
|
Quidel Corporation
QDEL
|
101 | $ 28.81 | 0.03 % | $ 1.21 B | ||
|
IQVIA Holdings
IQV
|
126 | $ 222.3 | 0.04 % | $ 40.3 B | ||
|
Guardant Health
GH
|
83.6 | $ 103.47 | 1.37 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
56.3 | $ 133.88 | -0.73 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 196.14 | 1.64 % | $ 10.1 B | ||
|
Quotient Limited
QTNT
|
86.2 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
18.3 | $ 183.36 | 0.47 % | $ 20.4 B | ||
|
Mettler-Toledo International
MTD
|
53.4 | $ 1 410.24 | 1.17 % | $ 29.9 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 | $ 262.29 | -0.71 % | $ 22 B | ||
|
Myriad Genetics
MYGN
|
42 | $ 7.01 | -2.84 % | $ 635 M | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 183.39 | -1.71 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
27 | $ 701.16 | -0.43 % | $ 57.8 B | ||
|
Lantheus Holdings
LNTH
|
25.3 | $ 67.34 | 1.08 % | $ 4.66 B | ||
|
NeoGenomics
NEO
|
20.7 | $ 12.07 | 1.81 % | $ 1.53 B | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 6.8 | -0.95 % | $ 1.47 B | ||
|
Agilent Technologies
A
|
50.1 | $ 140.63 | 0.69 % | $ 42.8 B | ||
|
Biomerica
BMRA
|
32.4 | $ 2.56 | 0.29 % | $ 5.88 M | ||
|
Bioventus
BVS
|
59.2 | $ 7.59 | 0.53 % | $ 475 M | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K |